Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

360
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

310
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

471
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
471
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

663
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
663
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.

International journal of impotence research·2006
Same author

A colonic polyp due to Langerhans cell histiocytosis: a lesion not to be confused with metastatic malignant melanoma.

Histopathology·2006
Same author

Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects.

Pediatric surgery international·2006
Same author

Single-stage repair of interrupted aortic arch and Taussig-Bing anomaly.

Pediatric cardiology·2006
Same author

Zingiber officinale exhibits behavioral radioprotection against radiation-induced CTA in a gender-specific manner.

Pharmacology, biochemistry, and behavior·2006
Same author

Length of insertion for pulmonary artery catheters to locate different cardiac chambers in patients undergoing cardiac surgery.

British journal of anaesthesia·2006

Related Experiment Video

Updated: Jan 8, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.1K

Cardiac hypertrophy: old concepts, new perspectives

M Gupta1, M P Gupta

  • 1Heart Institute for Children, Hope Childrens Hospital, Oak Lawn, IL 60463, USA.

Molecular and Cellular Biochemistry
|December 24, 1997
PubMed
Summary

Cardiac hypertrophy involves changes in myosin heavy chain (MHC) gene expression. Pressure overload down-regulates alpha-MHC and up-regulates beta-MHC, with slow recovery of beta-MHC after load removal, suggesting independent regulation.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Gene Regulation

Background:

  • Cardiac hypertrophy, an enlargement of the heart, is associated with altered gene expression.
  • Myosin heavy chain (MHC) isoforms play critical roles in cardiac contractility and are regulated during hypertrophy.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying changes in alpha- and beta-myosin heavy chain (MHC) gene expression during cardiac hypertrophy.
  • To elucidate the role of the adrenergic nervous system in regulating MHC gene expression.

Main Methods:

  • Induction of cardiac hypertrophy in rats via abdominal aorta constriction and subsequent load removal.
  • Quantification of alpha- and beta-MHC mRNA levels using molecular techniques.
  • Analysis of alpha-MHC gene promoter activity in primary fetal rat cardiac myocytes treated with cAMP-inducing agents.

More Related Videos

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.6K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.5K

Related Experiment Videos

Last Updated: Jan 8, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.1K
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.6K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.5K

Main Results:

  • Pressure overload led to decreased alpha-MHC mRNA and increased beta-MHC mRNA.
  • Load removal reversed hypertrophy and normalized alpha-MHC mRNA, but beta-MHC mRNA remained elevated for weeks.
  • cAMP-inducing agents, specifically 8-Br-cAMP, enhanced alpha-MHC promoter activity, with a critical regulatory region identified between -71 and -40 bp.

Conclusions:

  • Cardiac hypertrophy involves independent regulation of alpha- and beta-MHC genes by load-dependent signals.
  • The beta-adrenergic pathway, mediated by cAMP, plays a significant role in modulating alpha-MHC gene expression.
  • These findings provide insights into the molecular basis of cardiac adaptation to mechanical stress.